Blood‐based SNAP‐25 and VAMP‐2 in Alzheimer’s disease; relation to cognition, atrophy and synaptic density.

Mathias Sauer; Charlotte De Rocker; Lana Grötschel; Julie Goossens; Andrea L. Benedet; Michael Schöll; Johanna Nilsson; Ann Brinkmalm; Shorena Janelidze; Erik Stomrud; John T O'Brien; Leonidas Chouliaras; Maura Malpetti; Pedro Rosa‐Neto; James B. Rowe; Henrik Zetterberg; Kaj Blennow; Oskar Hansson; Eugeen Vanmechelen; Nicholas J. Ashton

Journal ArticleOPEN ACCESS

Blood‐based SNAP‐25 and VAMP‐2 in Alzheimer’s disease; relation to cognition, atrophy and synaptic density.

Sauer M
De Rocker C
Grötschel L
et al.

Alzheimer's & Dementia (2023) 19(S24)

DOI: 10.1002/alz.083128

N/ACitations

6Readers

Abstract

Background: A hallmark of neurodegenerative disorders is synaptic dysfunction and

Cite

CITATION STYLE

APA

Sauer, M., De Rocker, C., Grötschel, L., Goossens, J., Benedet, A. L., Schöll, M., … Ashton, N. J. (2023). Blood‐based SNAP‐25 and VAMP‐2 in Alzheimer’s disease; relation to cognition, atrophy and synaptic density. Alzheimer’s & Dementia, 19(S24). https://doi.org/10.1002/alz.083128

Blood‐based SNAP‐25 and VAMP‐2 in Alzheimer’s disease; relation to cognition, atrophy and synaptic density.

Abstract

Cite

Register to see more suggestions